BREAKING
Importance
85
Trust
71
Urgency
95
APPROVAL
Canada Approves Dr. Reddy’s Generic Version of Novo Nordisk’s Ozempic - WSJ
Canada approved Dr. Reddy's generic copy of semaglutide (Ozempic), Novo Nordisk's weight-loss and diabetes drug. This is the first generic version available in Canada and may lower the cost for patients who need the medication.
Analysis
Canada just got the first generic Ozempic. Novo loses its monopoly there, and Canadian patients may pay less for semaglutide.
- Canada approved Dr. Reddy's generic version of semaglutide (Ozempic)
- It is the first generic Ozempic available in Canada
- Generic could lower cost for diabetes and weight-loss patients
Novo Nordisk News1mo
Read